Medicamen Biotech Balance Sheet Annual

Trade

BSE: 531146 | NSE: MEDICAMEQ | ISIN: INE646B01010 | Sector: Biotechnology & Drugs

442.70 -5.35 (-1.19%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	14.79	20.78	3.82	1.66
Cashand Short Term Investments	14.79	20.78	3.82	1.66
Accounts Receivable- Trade Net	55.26	65.26	63.22	52.55
Total Receivables Net	59.75	88.70	84.76	79.11
Total Inventory	59.38	47.63	27.01	5.20
Other Current Assets Total	25.68	3.06	3.51	5.04
Total Current Assets	159.59	163.36	123.04	96.03
Property/ Plant/ Equipment Total- Net	90.95	91.76	92.12	89.43
Intangibles Net	0.90	0.90	0.36	0.20
Note Receivable- Long Term	1.22	1.11	0.87	0.78
Other Long Term Assets Total	41.86	21.39	9.31	7.56
Total Assets	294.52	278.52	225.69	194.01
Accounts Payable	45.42	47.59	43.30	32.21
Notes Payable/ Short Term Debt	29.56	23.31	19.27	10.93
Other Currentliabilities Total	16.04	10.15	8.67	8.65
Total Current Liabilities	91.03	82.57	72.69	53.27
Capital Lease Obligations	1.26	0.87	5.07	6.40
Total Long Term Debt	1.26	0.87	5.07	6.40
Total Debt	30.82	25.71	25.80	18.82
Other Liabilities Total	1.76	1.66	1.46	1.16
Total Liabilities	94.04	85.10	79.22	61.12
Common Stock Total	12.71	12.65	12.22	12.22
Retained Earnings( Accumulated Deficit)	187.77	82.69	66.55	52.97
Total Equity	200.49	193.41	146.47	132.89
Total Liabilities Shareholders' Equity	294.52	278.52	225.69	194.01
Total Common Shares Outstanding	1.27	1.27	1.22	1.22
Tangible Book Valueper Share Common Eq	156.97	152.17	119.60	108.61
Short Term Investments	-	0.00	0.00	-
Prepaid Expenses	-	3.19	3.94	5.02
Property/ Plant/ Equipment Total- Gross	-	128.85	123.34	115.00
Accumulated Depreciation Total	-	-37.10	-31.22	-25.56
Current Portof LT Debt/ Capital Leases	-	1.53	1.45	1.49
Additional Paid- In Capital	-	98.08	67.70	67.70
Deferred Income Tax	-	-	-	0.28